Cano Health, Inc. (CANO) — Financial statements
Income statement, balance sheet, and cash flow for Cano Health, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Revenue & Gross Profit | |||||
| Revenue | 2,739↑70.2% | 1,609↑93.5% | 832↑130.1% | 361 | |
| Cost of Revenue | 2,317↑64.3% | 1,410↑111.7% | 666↑134.1% | 285 | |
| Gross Profit | 422↑111.9% | 199↑20.4% | 165↑115.4% | 77 | |
| Operating Expenses | |||||
| R&D Expenses | 0.00 | 0.00 | 0.00 | 0.00 | |
| General & Administrative Expenses | 394↑56.4% | 252↑142.5% | 104↑75.8% | 59 | |
| Selling & Marketing Expenses | 28 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 422↑67.5% | 252↑142.5% | 104↑75.8% | 59 | |
| Other Expenses | 91↑83.3% | 49↑167.3% | 18↑171.2% | 7 | |
| Operating Expenses | 513↑70.1% | 302↑146.3% | 122↑85.6% | 66 | |
| Total Costs & Expenses | 2,830↑65.3% | 1,712↑117.0% | 789↑125.0% | 351 | |
| Operating Results | |||||
| Operating Income | -90↑12.6% | -103↓340.6% | 43↑294.4% | 11 | |
| Depreciation & Amortization | 91↑83.5% | 49↑167.0% | 18↑171.2% | 7 | |
| EBITDA | -198↓306.5% | -49↓169.5% | -18↓202.3% | 18 | |
| EBIT | -288↓194.1% | -98↓168.2% | -37↓16197.4% | 0.23 | |
| Interest & Other Income | |||||
| Net Interest Income | -62↓21.8% | -51↓52.3% | -34↓242.2% | -10 | |
| Interest Income | 0.01↑250.0% | 0.00↓98.8% | 0.32↑0.3% | 0.32 | |
| Interest Expense | 62↑21.8% | 51↑50.8% | 34↑234.6% | 10 | |
| Non-Operating Income | 199↑4425.5% | -5↓105.8% | 79↑898.8% | -10 | |
| Other Income / Expenses | -337↓2283.9% | -14↑87.5% | -113↓1020.0% | -10 | |
| Income Before Tax | -426↓265.2% | -117↓65.8% | -70↓256.0% | -20 | |
| Income Tax Expense | 2↑15307.1% | 0.01↓97.8% | 0.65↓93.4% | 10 | |
| Net Income & EPS | |||||
| Net Income from Continuing Operations | -428↓267.0% | -117↓64.3% | -71↓139.3% | -30 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -428↓267.0% | -117↓64.3% | -71↓139.3% | -30 | |
| Bottom-Line Net Income | -428↓267.0% | -117↓64.3% | -71↓139.3% | -30 | |
| EPS (Basic) | -87.60↓257.0% | -24.54↑42.6% | -42.75↓139.4% | -17.86 | |
| EPS (Diluted) | -87.60↓257.0% | -24.54↑42.6% | -42.75↓139.4% | -17.86 | |
| Weighted Average Shares | 5↑2.8% | 5↑186.1% | 2↑0.0% | 2 | |
| Weighted Average Diluted Shares | 5↑2.8% | 5↑186.1% | 2↑0.0% | 2 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.